ICBT (ICBT) Stock Price & Analysis
ICBT (ICBT) rose 0.00% to USD 0 as of July 25, 2026 at 20:37 UTC, according to Nexqual real-time market data.
ICBT last closed at USD 0; the session ranged USD 0–0 on volume of 19,080 shares. Market capitalization is $265.72M, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, July 25, 2026 at 20:37 UTC.
Key Statistics (as of July 25, 2026 at 20:37 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 19,080 shares |
| Market Cap | $265.72M |
| Exchange | PNK |
Technical Analysis (ICBT)
Nexqual's technical model rates ICBT "SELL" based on 0 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 20:37 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 0) |
Analyst Ratings (ICBT)
Wall Street analysts rate ICBT "None", per Nexqual as of July 25, 2026 at 20:37 UTC.
| Consensus Rating | None |
|---|
Earnings (ICBT)
Source: Nexqual, July 25, 2026 at 20:37 UTC.
Financials & Fundamentals (ICBT)
| Total Revenue | $12.15M |
|---|---|
| Revenue Growth (YoY) | +46.40% |
| Gross Margin | +10.14% |
| Operating Margin | -10.55% |
| Profit Margin | -6.08% |
| ROE | -200.75% |
| Current Ratio | 2.47 |
| Total Cash | $27,008 |
| Total Debt | $1.41M |
| Free Cash Flow | $-4.10M |
Source: Nexqual, July 25, 2026 at 20:37 UTC.
Financial Health Score (ICBT)
Nexqual rates ICBT's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 20:37 UTC.
| Growth | Strong — Revenue +46% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $27K cash vs $1M debt |
| Cash Flow | Weak — FCF negative: -$4M, burning cash |
| Efficiency | Critical — ROE -201%, ROA -11.2% |
Ownership (ICBT)
| Shares Outstanding | 4,287 |
|---|
Source: Nexqual, July 25, 2026 at 20:37 UTC.
Leadership (ICBT)
ICBT is led by Garth McIntosh (age 79), CEO & President, per Nexqual as of July 25, 2026 at 20:37 UTC.
| CEO & President | Garth McIntosh (age 79) |
|---|---|
| Chief Financial Officer | Gino Motafferi C.A. |
| Technical Director | Richard Howarth |
| Secretary & Director | John F. McNulty (age 75) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PDMI | Paradigm Medical Industries, In | USD 0 | ▲ 0% |
| INAR | InternetArray, Inc. | USD 0 | ▲ 0% |
| IGNT | INGEN TECHNOLOGIES INC | USD 0 | ▲ 0% |
| KGRI | THE KILEY GROUP INC | USD 0 | ▲ 0% |
| HESG | HEALTH SCIENCES GROUP INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 20:37 UTC. This page is informational and not investment advice.